This clinical study is evaluating a potential new drug for to treat Congenital Adrenal Hyperplasia.
Congenital Adrenal Hyperplasia is a genetic condition that affects how the adrenal glands make important hormones. The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 18–32.
Be 18 to 55 years old
Both males or females